Leadership & Pay ·
On August 19, 2026, the Board of Directors of Hepion Pharmaceuticals, Inc. approved the appointment of James Liddy as…
CTRVPHepion Pharmaceuticals, Inc.
On August 19, 2026, the Board of Directors of Hepion Pharmaceuticals, Inc. approved the appointment of James Liddy as a director, effective immediately. The filing confirms no arrangements or understandings existed between Mr. Liddy and other persons regarding his selection, nor are there reportable transactions under Regulation S-K Item 404(a). Hepion Pharmaceuticals operates in the biopharmaceutical industry, focusing on the development of therapies for rare diseases.